Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

(MedPage Today) -- The FDA approved olezarsen (Tryngolza) to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia, the agency announced on Wednesday. Olezarsen, an mRNA-targeted antisense oligonucleotide...

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)

CARLSBAD, Calif.--(BUSINESS WIRE)--Jun 24, 2026-